Background: The most abundant plant sterol β-sitosterol is widely used for treating heart diseases and chronic inflammatory conditions. The objective of the current study was to evaluate the nephroprotective effect of β-sitosterol against nephrotoxicants which were studied using renal function markers, antioxidant and lipid peroxidation status, and inflammatory markers. Methods: Male albino Wistar rats were randomly grouped into four: group 1 was vehicle control rats (0.1% carboxymethyl cellulose [CMC]); group 2 was rats treated with N-diethylnitrosamine (DEN) (200 mg/kg body weight [bw] i.p. on the 15th day) and ferric nitrilotriacetate (Fe-NTA) (9 mg/kg bw i.p. on 30th and 32nd days); group 3 was rats that received β-sitosterol (20 mg/kg bw in 0.1% CMC, p.o. for 32 days) 2 weeks prior to the exposure to the nephrotoxicant; and group 4 was rats that received β-sitosterol alone. The experiment was terminated after the 24 h of last dosage of Fe-NTA, and all the animals were sacrificed. The blood, liver and kidney from each group were analyzed for biochemical, molecular and histological changes. Results: All the parameters showed significant changes in DEN and Fe-NTA treated animals, whereas β-sitosterol pretreated animals' altered biochemical parameters were restored to near normal. Histopathological and
Introduction
A variety of diverse chemicals, including drugs, natural products, industrial chemicals and environmental pollutants cause nephrotoxicity when humans are exposed intentionally and unintentionally [1] . Drugs, especially nephrotoxins, cause approximately 20% of hospital-acquired episodes of renal failure [2] . Evidence is mounting regarding most anti-cancer agents that not only prevent cancer but also produce many side effects [3, 4] . Any therapy with side effects can lead to decrease in quality of life, compliance, treatment interruption, dose reductions and discontinuation of treatment, all of which may undermine therapeutic efficacy. The major reasons for the susceptibility of kidney to nephrotoxicants are that the kidney receives 25% of the cardiac output and many transporters result in high intracellular concentrations [5] . The tubular cells of the kidney are vulnerable to toxicant-mediated injury. In particular, proximal tubule cells are vulnerable to the toxic effects of drugs because their role in concentrating and reabsorbing glomerular filtrate exposes them to high levels of circulating toxins [6] . The mortality of acute renal failure is approximately 50%, which has not changed significantly in the last 40 years [7] . Therefore, successful prevention requires knowledge of pathogenic mechanisms of renal injury, patient-related risk factors and drug-related risk factors.
Research studies from the past half century have reported that excessive iron can promote a vast array of acute and chronic illnesses. Iron is now recognized as a risk factor for endocrinological, gastrointestinal, infectious, neoplasmic, neurodegenerative, obstetric, ophthalmic, orthopedic, pulmonary and vascular diseases [8, 9] . Nitrilotriacetic acid (NTA), a synthetic tricarboxylic acid, is a water contaminant and frequently used as a constituent of detergents in various places including hospitals, households and laundries in developing countries. Accumulated research studies suggested that NTA with iron complex, ferric nitrilotriacetate (Fe-NTA), a well-built nephrotoxic agent, produces acute and subacute proximal tubular necrosis in experimental animals [10, 11] . The auto-oxidation of Fe 2+ -NTA generates reactive oxygen species (ROS) leading to induction of lipid peroxidation and oxidative DNA damage by inducing oxidative stress. Renal toxicity is caused by the elevation of serum free iron concentration following its reduction at the luminal side of proximal tubules [12] . One of the most important environmental carcinogens, N-diethylnitrosamine (DEN), is an N-nitroso alkyl compound that reduces the time of treatment necessary to induce nephrotoxicity as compared with Fe-NTA alone treated animals [13] .
Increased nitric oxide (NO) production in the renal tissue is involved in the pathogenesis of nephrotoxicity [14] . Inducible nitric oxide synthase (iNOS) can produce excess amount of NO which reacts with the superoxide anion to generate the cytotoxic compound peroxy nitrite radical (NO·) that causes further cell damage by oxidizing and nitrating cellular macromolecules and also depletes intracellular reduced glutathione (GSH) thereby increasing the susceptibility to oxidative stress [15] . A large amount of NO·production could be responsible for the greater formation of ROS and reactive nitrogen species [16] .
Scavenging ROS by antioxidants is important in preventing damage to cellular components. Studies to date have proved that phytosterol has no obvious side effects and has been used to lower human blood lipid levels and prevent especially cardiovascular disease [17, 18] . β-sitosterol is a major phytosterol extracted from corn, soy, rice bran, wheat germ, peanuts, pumpkin seed and plant oils which have been reported in ancient medicinal history for its use in the treatment of nephritis and prostatitis [19] . Several studies have indicated that β-sitosterol inhibits cancer cell proliferation [20] and also exhibits anti-hypercholesterolemic, anti-inflammatory, anti-angiogenic, antidiabetic and immune modulating properties [21] [22] [23] . In this work, we aimed to explore the nephroprotective potential of β-sitosterol on DEN initiated and Fe-NTA promoted acute nephrotoxicity in Wistar rats by evaluating the role of β-sitosterol on lipid peroxidation, antioxidant status, kidney function markers, Nrf-2 gene expression, histopathological manifestations and iNOS expression. 
Materials and methods

Chemicals
Preparation of Fe-NTA
The Fe-NTA solution was prepared by the method of Awai et al. [24] as modified by Athar and Iqbal [13] . Briefly, ferric nitrate (0.16 mM) solution was mixed with a fourfold molar excess of the disodium salt of NTA (0.64 mm), and the pH was adjusted to 7.4 with a sodium bicarbonate solution. This solution was prepared fresh before each analysis.
Animals
Healthy adult male albino rats (8-10 weeks old; weighing 120-180 g) of Wistar strain were purchased from the National Institute of Nutrition, Hyderabad, India, and were maintained in the Central Animal House, Department of Experimental Medicine, Rajah Muthaiah Medical College and Hospital, Annamalai University, Annamalainagar, India. The animals were housed in polypropylene cages and were provided with a standard pellet diet (Amrut laboratory Animal Feed Mysore Feeds Limited, Bangalore, Karnataka, India) and water ad libitum. The animals were maintained under controlled conditions of temperature (23±2 °C) and humidity (65%-70%) with a 12 h light/dark cycle. All experiments were performed according to the Institutional Animal Ethics Committee approval and guidelines (160/1999/CPCSEA; Proposal No. 1041: dated 06.08.2013, Annamalai University).
Experimental design
A total number of 24 male albino Wistar rats were randomized into four groups (control and experimental) of six rats each. Group 1 rats served as the vehicle control (0.1% carboxymethyl cellulose [CMC] ). Group 2 and 3 rats were treated with DEN (200 mg/kg body weight [bw], single i.p.) injection on the 15th day and Fe-NTA (9 mg/kg bw, i.p.) on 30th and 32nd day. Group 2 rats received no other treatment. Group 3 rats were orally administered with β-sitosterol (20 mg/kg bw in 0.1% CMC, p.o.) daily for 32 days. This dosage was given 2 weeks prior to the exposure to the nephrotoxicant. Group 4 rats were orally administered with β-sitosterol alone throughout the experimental period. The experiment was terminated after 24 h of the last dosage of Fe-NTA, and all the animals were sacrificed by cervical dislocation.
Biochemical analysis
Biochemical studies were conducted on blood, liver and kidney of control and experimental animals in each group. Blood samples were collected both in heparinized tubes for plasma separation (centrifugation at 1000 × g for 15 min) and in a dry test tube for serum separation after coagulation at ambient temperature for 30 min (separated by centrifugation at 2000 × g for 10 min). Liver and kidney tissue samples from animals were washed with ice-cold saline and homogenized using appropriate buffer (thiobarbituric acid reactive Aliquots from these preparations (blood and tissues) were used for the lipid peroxidation TBARS [25, 26] , SOD [27] , CAT [28] , GPx [29] and GSH [30] . Blood urea was estimated by diacetyl monoxime method [31] . Serum creatinine was estimated by the alkaline picrate method [32] , and uric acid in plasma was estimated by the method of Brown [33] .
q-PCR
Total cellular RNA was extracted from renal tissue using Trizol reagent. The concentration and purity of RNA preparation were checked by a nano spectrophotometer (Implen, Germany) at absorbance 260 and 280 nm. Total RNA (2.0 μg) was reverse transcribed to cDNA in a reaction mixture containing 1 μL of oligo (dT) primer (0.2 μg/mL), 1 μL of RNase inhibitor (10 U/mL), 1 μL of 0.1 M DTT, 4 μL of 5 × reaction buffer, 2.0 μL of 30 mM dNTP mix (7.5 mM each), 0.5 μL of M-MuLV reverse transcriptase (50 U/μL) and made up to 20 μL with DEPC water and kept at 37 °C for 1 h and then heated at 95 °C for 2 min. The primer sequences for Nrf2 and GAPDH were as follows: 5′-CACATCCAGACAGACACCAGT-3′ as forward and 5′-CTA-CAAATGGGAATGTCTCTGC-3′ as reverse primer and 5′ACTCCCATTC-CTCCACCTTT3′ as forward and 5′TTACTCCTTGGAGGCCATGT3′ as reverse primer, respectively. PCR amplification was performed with the Roche LightCycler Quantification Kit. The PCR conditions were 
Histopathological examination
Histopathological investigations were performed on liver and kidney tissues for the control and experimental animals in each group.
Tissues were fixed at 10% buffered formalin and routinely processed and embedded in paraffin; 2-3 μm sections were cut on a rotary microtome, fixed on glass slides, and stained with hematoxylin and eosin.
Immunohistochemistry
Kidney tissues from control and experimental animals in each group were immediately fixed and embedded in paraffin wax from buffered formalin (10%). The cut sections (2-3 μm) were taken using rotary microtome and placed on polylysine coated clean glass slides for drying at 37 °C, and then it was used for immunohistochemical studies. Paraffin embedded tissue sections were dewaxed and rehydrated through graded ethanol with distilled water. Endogenous peroxidase was blocked by incubation with hydrogen peroxide (3%) in methanol for 10 min. The antigen retrieval was achieved by microwave in citrate buffer solution (pH 6.0) for 10 min, followed by washing step with Tris-buffered saline (pH 7.6). The tissue sections were then incubated with power Block TM reagent (BioGenex, San Ramon, CA, USA), universal proteinaceous blocking reagent, for 15 min at room temperature to block non-specific binding. These tissue sections were then incubated with specific primary antibody (iNOS -Neomarker, Thermo Scientific, USA) overnight at 4 °C. The bound primary antibody was incubated with the secondary antibody conjugated with horseradish peroxidase for 30 min at room temperature. After rinsing with Tris-buffered saline, the antigen-antibody complex was detected using 3,3′-diaminobenzidine (Sigma-Aldrich, USA), the substrate of horseradish peroxidase. When acceptable color intensity was reached, the slides were washed with counter stain hematoxylin and covered with a mounting medium.
Statistical analysis
Statistical analysis was performed using one-way analysis of variance, followed by Duncan's multiple range test (DMRT) using SPSS version 17.0 for windows (SPSS, Tokyo, Japan). Values are represented as mean±SD, and p < 0.05 was considered statistically significant.
Results
Effect of β-sitosterol on lipid peroxidation
Levels of TBARS in kidney, liver and plasma of control and experimental animals in each group are shown in Tables 1  and 2 . Levels of TBARS were significantly increased (p < 0.05) in kidney, liver and plasma of nephrotoxic rats (group 2) compared to control rats (group 1). Oral administration of β-sitosterol (20 mg/kg bw) pretreatment to DEN and Fe-NTA induced nephrotoxic animals (group 3) significantly decreased (p < 0.05) the level of TBARS to near normal range. Rats treated with β-sitosterol alone (group 4) showed no significant difference in the level of TBARS when compared to control rats (group 1).
Effect of β-sitosterol on antioxidant status
Status of enzymatic antioxidants (SOD, CAT and GPx) and non-enzymatic antioxidant (GSH) in kidney, liver and plasma of control and experimental animals in each group are shown in Tables 1 and 2 . The activity of SOD, CAT, GPx and GSH were significantly decreased (p < 0.05) in kidney, liver and plasma of DEN and Fe-NTA induced nephrotoxic rats (group 2) compared to control rats (group 1). Oral administration of β-sitosterol (20 mg/kg bw) pretreatment (group 3) significantly prevented the decrease in the activities of antioxidant enzymes induced by the DEN and Fe-NTA. Rats treated with β-sitosterol alone (group 4) showed no significant difference in levels of antioxidants when compared to control rats (group 1).
Effect of β-sitosterol on kidney function markers
The levels of renal function markers like urea, uric acid and creatinine in control and experimental animals of each group were shown in Table 3 . The levels of kidney function markers were significantly increased (p < 0.05) in DEN and Fe-NTA treated rats (group 2) compared to control rats (group 1). Pretreatment of β-sitosterol (20 mg/kg bw) to DEN and Fe-NTA treated animals (group 3) reversed the status of urinary markers to near normal status. No significant difference could be seen in the rats of control (group 1) and those treated with β-sitosterol alone (group 4).
Effect of β-sitosterol on Nrf2 gene expression
Nrf2 mRNA expression patterns of control and experimental rats are depicted in Figure 1 . DEN and Fe-NTA treated rats (group 2) showed significant decrease (p < 0.05) in the mRNA expression of Nrf2 when compared to control rats. β-Sitosterol (20 mg/kg bw) pretreatment to DEN and Fe-NTA treated rats significantly improved the expression of Nrf2 (group 3). Similar patterns of Nrf2 mRNA expression was observed in control rats (group 1) and rats treated with β-sitosterol alone (group 4).
Histopathology
Histopathological manifestations in kidney tissues of the control and experimental animals are presented in Figure 2 . Kidney tissues from control rats (group 1) and β-sitosterol alone treated rats (group 4) showed a normal architecture. The acute nephrotoxicity was confirmed by evaluating the pathological symptoms such as proximal tubular necrosis, degeneration of epithelial lining and hyaline cast, which were observed in DEN and Fe-NTA alone treated rats (group 2). However, β-sitosterol pretreatment to DEN and Fe-NTA treated rats (group 3) showed mild degeneration of the epithelial lining. The histopathological changes in liver tissues of the control and experimental rats are presented in Figure 3 . Liver tissues from control rats (group 1) and β-sitosterol alone treated rats (group 4) showed the normal architecture of the cell. The liver damage was confirmed by evaluating the pathological symptoms such as degeneration and dilation of central vein, which was observed in DEN and Fe-NTA alone treated rats (group 2). However, β-sitosterol pretreatment to DEN and Fe-NTA treated rats (group 3) showed mild degeneration of hepatocytes and decreased sinusoidal space. The histopathological data from kidney and liver tissues correlate with the biochemical endpoints.
Effect of β-sitosterol on renal inflammation
The immuno-expression pattern of iNOS in kidney tissues is shown in Figure 4 . Positive staining in kidney tissues was characterized by a strong cytoplasmic staining pattern. A strong positive staining for iNOS was observed in kidney tissues of nephrotoxicity induced rats (group 2) and negative staining for control rats (group 1) and rats treated with β-sitosterol alone (group 4). In group 3 rats, oral administration of β-sitosterol pretreatment significantly down-regulated the expression of iNOS which was up-regulated by DEN and Fe-NTA.
Discussion
The number of people exposed to more diagnostic and therapeutic procedures with the potential to harm kidney function is still increasing [34] . Recently, there has been an increasing attention to screen the protective function of antioxidants from a large number of traditional plants that are expected to decrease the susceptibility of kidney from oxidative challenges and to extend our life span. Even though the defense systems of our own enzymatic and non-enzymatic antioxidants preserve the redox status, they become overwhelmed during oxidative stress due to an imbalance caused by excessive generation of ROS [35] . Unmanageable production of ROS contributes to the pathogenesis of cancer, cardiovascular disorders, etc [36] . It has long been recognized that ROS causes structural and functional impairments of cellular components like lipids, proteins and nucleic acid. Numerous scientific efforts have been put forward to counteract the effects of ROS by reinforcing the antioxidant defense systems by exploration of safe and effective phytochemicals to manage renal disease [12, 37] . The toxic effect of ROS and free radicals can be eliminated by SOD which eliminates O 2 − to produce H 2 O 2 . Further, GPx and CAT are involved in peroxide metabolism. Glutathione, a most abundant thiol, acts as a free radical scavenger to directly react with an oxygen radical. Thus, it is used as an electron donor for GPx during reduction of peroxides. The obstructed kidneys show down-regulation of antioxidant enzymes, which causes increased susceptibility to oxidative damage [38] . After Fe-NTA exposure, the renal injuries may be promoted due to the generation of ROS, leading to oxidative damage, increase lipid peroxidation and depletion in the activities of antioxidant enzymes, and also decrease in the GSH content was noted in group 2 rats, suggesting that much of the GSH stores were exhausted in eliminating the ROS produced by Fe-NTA. A possible key mechanism exerted by β-sitosterol to protect against oxidative stress may involve the strengthening of intracellular antioxidant defense which is consistent with the decreased levels of O 2 − and H 2 O 2 and also its regulation of the GSH redox cycle by preventing ROS accumulation. β-sitosterol has binding affinity for estrogen receptors, and estrogen acts as an antioxidant or via the stimulation of antioxidant enzymes [39] .
Previous studies reported that Fe-NTA induces acute proximal tubular necrosis, as a consequence of lipid peroxidation and oxidative tissue damage [11, 12] . This coincides with the histopathological examination of the Fe-NTA treated rats. However, kidney and liver from β-sitosterol pretreatment suppressed the toxic effects of DEN and Fe-NTA, and it was confirmed by respective histopathological photomicrographs showing mild degeneration of cells. Thus, we concluded that treatment with the β-sitosterol 20 mg/kg bw ameliorated the toxic manifestations of DEN and Fe-NTA in kidney and liver. Nitric oxide is an important regulatory molecule in both inflammation and cancer. It is controlled by nitric oxide synthase such as iNOS, eNOS and nNOS. iNOS is one of three key enzymes generating nitric oxide from the amino acid L-arginine. Several lines of evidence have explained the concept that inflammation is a critical component of chronic diseases [40] [41] [42] . iNOS is highly expressed in macrophages and leads to organ destruction in inflammatory diseases. A previous study has shown that Fe-NTA potently induces NO generation in cultured proximal tubule cells [14] . Our results also corroborated the earlier report. Reduction of iNOS expression in the present study may account for the beneficial effect of β-sitosterol on acute renal damage induced by Fe-NTA. Several in vivo and in vitro studies supported the anti-inflammatory effect of β-sitosterol and its involvement in the inflammatory cascade [43, 44] . Compounds able to reduce NO production by iNOS may be thus attractive as anti-inflammatory agents, and for this reason, the effects of β-sitosterol on iNOS activity have been intensively studied. iNOS inhibition by β-sitosterol pretreatment is considered to be an important mechanism implicated in its anti-inflammatory activity, which is mainly due to the stereochemistry of the hydroxyl group of β-sitosterol [45] .
Nrf2 is a redox-sensitive basic leucine zipper, a master regulatory transcription factor that regulates genes involved in the regulation of glutathione's synthesis and conjugation, antioxidant proteins and drug metabolizing enzymes [46] . Under unstimulated condition, Nrf2 is sequestered in the cytoplasm by Keap 1, while after exposure to oxidative insults Nrf2 is translocated into the nucleus and activates the antioxidant response element (ARE). The Nrf2/ARE signaling pathway plays a key role in activating cellular antioxidants and is widely expressed in tissues, especially in the kidney [47] . Under physiological conditions, nuclear Nrf2 is needed for the maintenance of cellular homeostasis. Nrf2 gene has been shown to intensify inflammation and exacerbate ROS production, oxidative DNA damage and renal injury, indicating that Nrf2 is crucial in ameliorating renal damage [48] . Elevated oxidative stress can modify the number of cellular targets and cause cell damage. The two mechanisms include phosphorylation of Nrf2 and electrophilic modification of sulfhydryl groups in keap 1 cysteine residues that have been proposed for dissociation of Nrf2-keap 1 complex that remained in the unbound form after exposure to electrophiles. Modulation of keap 1/Nrf2/ARE system is a potential pharmacological target for ameliorating oxidative stress caused by ROS and electrophiles. Oral administration of β-sitosterol pretreatment to DEN and Fe-NTA treated rats showed a significant increase in the Nrf2 gene expression, which suggested that β-sitosterol activates the Nrf2 regulatory transcription system for antioxidant enzymes including GSH synthesis, hydrogen peroxide removal, detoxification and drug excretion.
Filtration and excretion of nitrogenous waste products from the blood is one of the most important functions of the kidney. The kidney function markers like urea, uric acid and creatinine are breakdown products of normal body processes and are eliminated by the kidneys. If the kidneys malfunction, they are unable to eliminate these substances with ease. As a result, the blood urea and creatinine levels will increase. The measurements of elevated urea and creatinine serve as indicators of decreased renal function. Moreover, the kidney function markers like urea, uric acid and creatinine showed a marked elevation in Fe-NTA alone treated rats in accordance with previous reports [11, 12] . Oral administration of β-sitosterol at the dose 20 mg/kg bw markedly reduced all the above markers to near normal; this is mainly due to the improved antioxidant status thereby detoxifying both endogenous and exogenous toxicants. These results suggested that β-sitosterol may protect against Fe-NTA promoted renal toxicity and might serve as a novel protective agent to limit renal injury. β-sitosterol is one of the most prevalent phytosterols that shows important characteristics of common phytosterol, i.e. four-ring steroid nucleus, three β-hydroxyl groups and five 6-carbon double bonds; this plays a pivotal role in the stabilization of phospholipid bilayers in the cell membranes [49] . Thus, we conclude that β-sitosterol might protect the renal cell membranes against the nephrotoxicants due to the presence of these functional groups.
